Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,661 to 1,680 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma. | Blood | 2019 | 31292115 | PubTator, text mining | PubMed |
| A novel mechanism for immune regulation after human lung transplantation. | J Thorac Cardiovasc Surg | 2019 | 31288367 | PubTator, text mining | PubMed |
| The Rheumatoid Arthritis Risk Gene AIRE Is Induced by Cytokines in Fibroblast-Like Synoviocytes and Augments the Pro-inflammatory Response. | Front Immunol | 2019 | 31275320 | PubTator, text mining | PubMed |
| Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application. | Cancers (Basel) | 2019 | 31261914 | PubTator, text mining | PubMed |
| NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPARγ. | Nat Commun | 2019 | 31253783 | PubTator, text mining | PubMed |
| Potential immune escape mechanisms underlying the distinct clinical outcome of immune checkpoint blockades in small cell lung cancer. | J Hematol Oncol | 2019 | 31253167 | PubTator, text mining | PubMed |
| Single cell RNA-Seq reveals pre-cDCs fate determined by transcription factor combinatorial dose. | BMC Mol Cell Biol | 2019 | 31253076 | PubTator, text mining | PubMed |
| Induced Pluripotent Stem Cell (iPSC)-Derived Lymphocytes for Adoptive Cell Immunotherapy: Recent Advances and Challenges. | Curr Hematol Malig Rep | 2019 | 31243643 | PubTator, text mining | PubMed |
| Utility of Circulating Cell-Free RNA Analysis for the Characterization of Global Transcriptome Profiles of Multiple Myeloma Patients. | Cancers (Basel) | 2019 | 31242667 | PubTator, text mining | PubMed |
| Epstein-Barr Virus and Innate Immunity: Friends or Foes? | Microorganisms | 2019 | 31238570 | PubTator, text mining | PubMed |
| Non-Invasive Biomarkers for Celiac Disease. | J Clin Med | 2019 | 31234270 | PubTator, text mining | PubMed |
| Ontogeny, Genetics, Molecular Biology, and Classification of B- and T-Cell Non-Hodgkin Lymphoma. | Hematol Oncol Clin North Am | 2019 | 31229154 | PubTator, text mining | PubMed |
| BioTarget: A Computational Framework Identifying Cancer Type Specific Transcriptional Targets of Immune Response Pathways. | Sci Rep | 2019 | 31227749 | PubTator, text mining | PubMed |
| Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade. | Nat Commun | 2019 | 31217437 | PubTator, text mining | PubMed |
| Chromatin Architecture as an Essential Determinant of Dendritic Cell Function. | Front Immunol | 2019 | 31214161 | PubTator, text mining | PubMed |
| Analysis of Genes Involved in Ulcerative Colitis Activity and Tumorigenesis Through Systematic Mining of Gene Co-expression Networks. | Front Physiol | 2019 | 31214045 | PubTator, text mining | PubMed |
| Expressions of HLA Class II Genes in Cutaneous Melanoma Were Associated with Clinical Outcome: Bioinformatics Approaches and Systematic Analysis of Public Microarray and RNA-Seq Datasets. | Diagnostics (Basel) | 2019 | 31212865 | PubTator, text mining | PubMed |
| miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS. | Ann Clin Transl Neurol | 2019 | 31211169 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibition in Classical Hodgkin Lymphoma: From Early Achievements towards New Perspectives. | J Oncol | 2019 | 31205470 | PubTator, text mining | PubMed |
| Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders. | Stem Cells Int | 2019 | 31191673 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=84